Qianjiang Yongan Pharmaceutical Co., Ltd. (002365) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Qianjiang Yongan Pharmaceutical Co., Ltd.

Why is Qianjiang Yongan Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 5.32%

The company has been able to generate a Return on Capital Employed (avg) of 5.32% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -7.73% and Operating profit at -141.03% over the last 5 years

The company has declared positive results in Mar'2026 after 4 consecutive negative quarters

ROCE(HY) Highest at 1.74%
DEBTORS TURNOVER RATIO(HY) Highest at 5.45 times
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost

With ROE of 1.20%, it has a expensive valuation with a 1.35 Price to Book Value

Over the past year, while the stock has generated a return of -58.10%, its profits have fallen by -18%
At the current price, the company has a high dividend yield of 1.1

Below par performance in long term as well as near term

Along with generating -58.10% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Qianjiang Yongan Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Specialty Chemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Qianjiang Yongan Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Qianjiang Yongan Pharmaceutical Co., Ltd.

-100.0%

1.50

36.67%

China Shanghai Composite

21.43%

1.73

13.79%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-7.73%

EBIT Growth (5y)

-141.03%

EBIT to Interest (avg)

14.14

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.44

Sales to Capital Employed (avg)

0.41

Tax Ratio

18.84%

Dividend Payout Ratio

128.53%

Pledged Shares

Institutional Holding

ROCE (avg)

5.32%

ROE (avg)

4.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

113

Industry P/E

Price to Book Value

1.35

EV to EBIT

-1426.13

EV to EBITDA

20.94

EV to Capital Employed

1.63

EV to Sales

2.15

PEG Ratio

Dividend Yield

1.09%

ROCE (Latest)

-0.11%

ROE (Latest)

1.20%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company

ROCE(HY)

Highest at 1.74%

DEBTORS TURNOVER RATIO(HY)

Highest at 5.45 times

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -283.07% (YoY

NET SALES(Q)

Highest at CNY 235.9 MM

PRE-TAX PROFIT(Q)

Highest at CNY 11.82 MM

NET PROFIT(Q)

At CNY 10.75 MM has Grown at 79.72%

-5What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 140.84 MM

OPERATING PROFIT(Q)

Lowest at CNY 10.72 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.55 %

Here's what is working for Qianjiang Yongan Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 11.82 MM has Grown at 607.35%

over average net sales of the previous four periods of CNY 1.67 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Debtors Turnover Ratio

Highest at 5.45 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales

Highest at CNY 235.9 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 235.9 MM has Grown at 20.93%

over average net sales of the previous four periods of CNY 195.06 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 11.82 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 10.75 MM has Grown at 79.72%

over average net sales of the previous four periods of CNY 5.98 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost

Fallen by -283.07% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Qianjiang Yongan Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 140.84 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 10.72 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 4.55 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales